Eureka Therapeutics Company
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Technology:
CAR-T therapy, Cell-based gene therapy
Industry:
Private
Headquarters:
Emeryville, California, United States
Founded Date:
2006-01-01
Employees Number:
51-100
Funding Status:
Late Stage Venture
Investors Number:
8
Total Funding:
128901450
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-03-17
Last Funding Type:
Series E
Register and Claim Ownership